TransCode Therapeutics In...

NASDAQ: RNAZ · Real-Time Price · USD
6.82
-0.08 (-1.16%)
At close: May 30, 2025, 3:59 PM
6.85
0.51%
After-hours: May 30, 2025, 04:53 PM EDT

TransCode Therapeutics Revenue

TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
7
Market Cap
5.68M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.